Последние новости

Реклама

В.В СКЛЯРЕВИЧ. Антибактериальные лекарственые средства. Методы стандартизации препаратов. Раздел 2

В.В СКЛЯРЕВИЧ. Антибактериальные лекарственые средства. Методы стандартизации препаратов. Страница 131

5. Drusano G. L., Craig W. A. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections // J. Chemother. — 1997. — Vol. 9, Suppl. 3. — P. 38—44.

6. Craig W. A. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men // Clin. Infect. Dis. — 1998. - Vol. 26. - P. 1-10.

7. Moore R. D., Lietman P. S., Smith C. R. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration // J. Infect. Dis. — 1987. — Vol. 155. — P. 93-99.

8. Dunbar L. M.y Wunderink R. G., Habib M. P. et al. High-dose, short- course levofloxacin for community-acquired pneumonia: a new treatment paradigm // Clin. Infect. Dis. — 2003. — Vol. 37 (6). — P. 752— 760.

9. Craig W. A., Andes D. R. Correlation of the Magnitude of the AUC24/ MIC for 6 Fluoroquinolones against Streptococcus pneumoniaewith Survival and Bactericidal Activity in an Animal Model. — In: Abstracts of the 40th ICAAC, Toronto, Canada, Sept. 17—20, 2000. — Abs-289.

10. Lister P. D. Pharmacodynamics of Gatifloxacin Against Streptococcus pneumoniaein an in vitro Pharmacokinetic Model: Impact of AUC: MIC Ratios on Eradication // Antimicob Agents and Chemother. — 2002. - Vol. 46. - P. 69-74.

11. Craig W. A., Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media 11 Pediatr. Infect. Dis. J. — 1996. — Vol. 15. — P. 255-259.

12. Craig W. A. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins 11 Diagn. Microbiol. Infect. Dis. — 1995. — Vol. 22. — P. 89-96.

13. Mandell G. L. (ed). Principles and Practice of infection Diseases. — ed. 4. - NY, 1995. - P. 233-264.